We at CannaCare are committed to producing high-quality 100% organic cannabis for medicinal use. Our mission is to become the preferred supplier to medical wholesalers and manufacturers in Europe. Our vision is to help establish Portugal as the leader of Europe’s rapidly evolving medicinal cannabis market.

About Us

Our business is led by a renowned award-winning Master Grower and an expert Chief Science Officer. We have a dedicated local team of cultivators, an international lineup of highly accomplished scientists and a keenly committed group of shareholders. All of us are passionate about expanding Portugal’s nascent medicinal cannabis industry. We are enthusiastic about building a sustainable homegrown enterprise and recognise Portugal as a welcoming place to invest and do business.

We received our license from Infarmed, Portugal’s National Authority of Medicines and Health on 23 November 2023.

GMP dry flower will be available for sale to medicinal wholesalers and manufacturers in Europe, United Kingdom and Australia in summer 2024.

Our Cannabis

We value powerful chemistry and distinctive characteristics such as terpenes, taste and flavour. These attributes will soon become more valuable to manufacturers and wholesalers as Europe’s medicinal cannabis market becomes more sophisticated.

We currently work with one of the world’s top seed suppliers to curate the genetics of our cultivars and we are in the process of developing our own genetics’ portfolio. Our in-house R&D team is focused on the development of proprietary strains. This will allow us to vertically integrate and ultimately serve as a key building block for us to become fully independent industry leaders.


Our potent and flavourful packaged dry flower will be available for purchase in summer 2024.

Our Process

We concentrate on excellence. Our process begins with germinating top-quality seeds to produce our own clones. We analyse everything from the nutrients in the soil to the water used so that we can ensure quality and remove contaminants or pests. Our seeds are planted with comfortable spaces between them so that the plants receive an appropriate amount of light and water and have room to thrive. Our outdoor grow benefits from natural sunshine, organic pollination and fresh air.

Our pharmaceutical grade packaged flower meets all regulatory requirements in accordance with good medicine manufacturing rules (GMP).

Our Commitment

CannaCare operates with the following key principles and goals:

SCIENCE

Bring the best practices of international cannabis science to Portuguese cultivation.

FLOWER

Offer top quality dry flower appropriate for pharmaceutical use and adaptable for different therapies in Europe and beyond.

OPERATIONS

To be recognised for strong governance and meticulous regulatory compliance.

LOCATION

Contribute to the expanding role of Portugal in Europe’s medicinal cannabis landscape.

PRODUCT

To be known for best-in-class agricultural methods (GACP) which deliver GMP compliant dry flower.

BUSINESS

Create local jobs in order to build a robust team of Portuguese and international professionals dedicated to cannabis cultivation.

Medical Uses

It is a defining and exciting time for Europe’s medicinal cannabis industry. As expanding medical research uncovers more uses for cannabis, legislation and medical licensing is modernising to support new treatments. In Portugal, medical cannabis is currently licensed for the following uses:

  • Chronic pain caused by cancer or nervous system diseases such as neuropathy, phantom limb pain, trigeminal neuralgia, shingles

  • Post traumatic stress disorder

  • Side effects of cancer treatment

  • Spasticity associated with multiple sclerosis or spinal cord injuries

  • Nausea and vomiting resulting from chemotherapy, radiotherapy, HIV combination therapy and medication for Hepatitis C

  • Appetite stimulation in palliative care for cancer and AIDS patients

  • Tourette syndrome

  • Epilepsy and childhood disorders such as Dravet and Lennox Gastaut

  • Therapy resistant glaucoma

Our Team

Sergio Neto

Sergio started in the cannabis industry in 2018, obtaining his CTU certification in Cannabis growing, cooking and extraction, bud tending, operations, delivery service and the Portuguese laws and regulations. He co-founded Pure Healing, the first Portuguese company to have a license to grow, import and export medicinal cannabis. He has tested more than 20 different genetics with varying levels of THCV and CBG, and in 2021, he produced the most potent cannabis auto-flower in the world.

Dr. Ari Mackler

A scientist-turned-business professional who began his career in big Pharma, Ari transitioned into big CPG (food, nutrition, and health tech), working for The Wonderful Company, before pivoting into the world of start-ups with PLUS Products, the California-based cannabis company and The Seder Group.  Today, as a partner in G3V, Ari focuses his attention on developing business opportunities across cannabis, CPG, health-tech, and media.

Dina Guimaraes

Dina joined CannaCare in February 2023 after serving as the technical director at cannabis company Pure Healing. She is excited to contribute to the development of exclusive, high-quality plants to be used in scientific and medical applications. Dina is fascinated by biological species of pharmacological interest and previously worked for Infarmed as well as GlaxoSmithKline. She holds a degree in Chemistry from the University of Lisbon.

Contact Us

CannaCare LDA
Ruados Navegantes
Beloura Business Center, Bloco 4
São Pedro de Penaferrim, Portugal